Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway: Inhibitors of the WNT/Β-Catenin Signaling Pathway as Novel Anticancer Drugs
Journal of Pharmacological Sciences - Japan
doi 10.1254/jphs.08r28fm
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2009
Authors
Publisher
Japanese Pharmacological Society